Cart
sales@molnova.com
Atractylenolide I
CAS No. 73069-13-3
Atractylenolide I( —— )
Catalog No. M19047 CAS No. 73069-13-3
Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 91 | In Stock |
|
| 5MG | 75 | In Stock |
|
| 10MG | 126 | In Stock |
|
| 25MG | 240 | In Stock |
|
| 50MG | 415 | In Stock |
|
| 100MG | 579 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtractylenolide I
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.
-
DescriptionAtractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTNF-α| IL-6
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number73069-13-3
-
Formula Weight230.3
-
Molecular FormulaC15H18O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 434.22 mM
-
SMILESCC1=C2CC3C(=C)CCCC3(C=C2OC1=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
7-Bromoquinazoline-2...
7-Bromoquinazoline-2,4(1H,3H)-Dione is a marine derived natural products found in Pyura sacciformis.
-
Ac-IEVDID (TFA)
Ac-IEVDID TFA is a short peptide sequence with Ac at the end.
-
Ziftomenib
Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity, suitable for leukemia research.
